New Molecule Found Effective Against COVID-19
ATN-161, a small pentapeptide ?5?1 integrin inhibitor, has several properties that make it potentially attractive as a novel SARS-CoV-2 therapy. It is safe and well tolerated with no dose-limiting toxicity as per phase I cancer clinical trials . K18-hACE c57BL/6 J mice were inoculated with either saline or SARS-CoV-2 via intranasal administration. Post inoculation, one group of infected mice received ATN-161 (1 mg/kg), while the other received saline. The viral copy number, SARS-CoV2 gene expression, SARS-CoV2 antigen detection and histological studies of the lungs were carried out. The results were compared between infected mice with and without ATN-161 therapy.
Related Bookmarks
- COVID-Induced Chemosensory Dysfunctions Persist For 7 Months
- Increasing concerns about vector borne diseases, urbanization, and increased health consciousness ha
- Best Tips For Anger Management by Joan Warren
- Bootcamp Fitness Program | Warrior Fitness Camp
- General Anesthesia Drugs; Anesthetics Used to Induce Unconsciousness during Surgery
- Eye Health Ingredients are an essential part of eye treatment, in order to prevent any damage and ma
- Cenforce soft for effective result of ED
- Provigil Pills Store
- Holistic Skin Treatment in Melbourne | Psoriasis Eczema Clinic
- Herbal Products - Online Herbal Store In Pakistan
Recent Profiles
Jackie Menes
Old Postcards
Tỷ Lệ Kèo Nhà Cái
Red Oak Roofworks And Restoration
Abergavenny Roofing
Rs Interior Mk
Tarik
Night Udaipur
Archana Holly Springs
Dong Ho